[144] Xylem Inc SEC Filing

Rhea-AI Filing Summary

Form 144 filed for Xylem Inc. (XYL) reporting a proposed sale of 4,900 shares of common stock through Goldman Sachs & Co. LLC on 08/18/2025. The filing lists an aggregate market value of $690,165 and indicates 243,409,688 shares outstanding for the issuer. The shares to be sold were acquired as restricted stock units (compensation) on multiple dates between 02/16/2023 and 05/12/2025, in lots of 915, 1187, 1633, 3, 7 and 1155 shares respectively. The filer attests they are not aware of undisclosed material adverse information about the issuer. No sales in the past three months were reported.

Insights

Securities Analyst

TL;DR: Insider plans modest sale of 4,900 XYL shares (worth $690k); holdings were received as RSUs across 2023-2025.

The filing is a routine Rule 144 notice documenting a proposed sale of previously granted restricted stock units that vested or were acquired as compensation. The sale size (4,900 shares) represents a very small fraction of the reported 243,409,688 shares outstanding, so it is unlikely to be material to company capitalization. The disclosure through a broker (Goldman Sachs) and the attestation about lack of undisclosed material information are standard compliance elements. There are no reported sales in the past three months, which suggests this is not part of an active recent selling pattern according to this filing.

Corporate Governance Expert

TL;DR: This is a standard insider sale notice tied to compensation awards; documentation and timing appear routine.

The Form 144 lists the acquisition source as compensation — Restricted Stock Units on multiple dates, indicating these shares derive from equity compensation rather than open-market purchases or gifts. The filer provides the broker and planned sale date, fulfilling procedural requirements under Rule 144. The declaration regarding material adverse information is the customary attestation; no governance red flags or compliance exceptions are identified within the filing text itself.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	4900	690165	243409688	08/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/15/2024	Acquired as compensation -- Restricted Stock Units	Issuer			1633	05/15/2024	Compensation
Common	03/21/2024	Acquired as compensation -- Restricted Stock Units	Issuer			3	03/21/2024	Compensation
Common	06/28/2024	Acquired as compensation -- Restricted Stock Units	Issuer			7	06/28/2024	Compensation
Common	05/12/2025	Acquired as compensation -- Restricted Stock Units	Issuer			1155	05/12/2025	Compensation
Common	02/07/2024	Acquired as compensation -- Restricted Stock Units	Issuer			1187	02/07/2024	Compensation
Common	02/16/2023	Acquired as compensation -- Restricted Stock Units	Issuer			915	02/16/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)